![]() |
|
|
Vol. 288, Issue 3, 1192-1198, March 1999
Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, California
| |
Abstract |
|---|
|
|
|---|
Polyspecific organic cation transporters in epithelia play an important
role in the elimination of many endogenous bioactive amines and
therapeutically important drugs. Recently, the first human organic
cation transporter (hOCT1) was cloned from liver. The purpose of the
current study was to determine the effect of molecular size and
hydrophobicity on the transport of organic cations by hOCT1. We studied
the interaction of a series of n-tetraalkylammonium (n-TAA) compounds (alkyl chain length, N, ranging from 1 to 6 carbons) with hOCT1 in a transiently transfected human cell line, HeLa. [14C]tetraethylammonium (TEA) uptake was measured
under different experimental conditions. Both
cis-inhibition and trans-stimulation studies were carried out. With the exception of
tetramethylammonium, all of the n-TAAs
significantly inhibited [14C]TEA uptake. A reversed
correlation of IC50 values (range, 3.0-260 µM) with
alkyl chain lengths or partition coefficients (LogP) was observed.
trans-Stimulation studies revealed that TEA,
tetrapropylammonium, tetrabutylammonium, as well as
tributylmethylammonium trans-stimulated TEA uptake
mediated by hOCT1. In contrast, tetramethylammonium and
tetrapentylammonium did not trans-stimulate
[14C]TEA uptake, and tetrahexylammonium demonstrated an
apparent "trans-inhibition" effect. These data
indicate that with increasing alkyl chain lengths (N
2),
n-TAA compounds are more poorly translocated by hOCT1
although their potency of inhibition increases. Similar findings were
obtained with nonaliphatic hydrocarbons. These data suggest that a
balance between hydrophobic and hydrophilic properties is necessary for
binding and subsequent translocation by hOCT1.
| |
Introduction |
|---|
|
|
|---|
It
is widely recognized that an array of organic cations with diverse
chemical structures undergo hepatobiliary secretion (Meijer et al.,
1990
; Oude Elferink et al., 1995
; Groothuis and Meijer, 1996
). Distinct
transporters for small molecular weight, hydrophilic (type I) and large
molecular weight, bulkier (type II) organic cations appear to be
involved in the uptake of organic cations across the sinusoidal
membrane of the hepatocyte (Mol et al., 1988
; Meijer et al., 1990
;
Steen et al., 1991
; Moseley et al., 1992
; Oude Elferink et al., 1995
;
Moseley et al., 1996
). Previous studies demonstrated that lipophilicity
was a major determinant for the hepatobiliary transport of a series of
small molecular mass monoquaternary compounds (<200 Da; type I
compounds) in the rat. That is, increasing lipophilicity was associated
with increasing hepatic clearances of these compounds (Neef and Meijer,
1984
). However, because the studies were carried out in vivo, the
specific transporters involved in the hepatic clearance of these
compounds were not identified. Furthermore, the structure activity
relationships established in these studies were limited to
hepatobiliary secretion in the rat. It is not known whether such
relationships also describe the hepatobiliary transport of organic
cations in the human.
Recently, the first human organic cation transporter (hOCT1) was cloned
(Gorboulev et al., 1997
; Zhang et al., 1997b
). Northern blot analysis
demonstrated that hOCT1 is expressed primarily in human liver.
Functional studies carried out in Xenopus laevis oocytes
suggest that hOCT1 represents an organic cation transporter located on
the sinusoidal side of the hepatocyte (Zhang et al., 1997b
). To study
the functional properties of hOCT1, we developed a transiently
transfected cell line, HeLa (Zhang et al., 1998b
). We determined the
effect of various organic cations and other compounds on the transport
of the model organic cation, tetraethylammonium (TEA). Our data suggest
that a number of organic cations with diverse structures inhibited TEA
uptake in hOCT1 DNA-transfected HeLa cells (Zhang et al., 1998b
). In
addition, we observed that TEA and 1-methyl-4-phenylpyridinium, known
substrates of hOCT1, trans-stimulated the uptake of
[14C]TEA. Namely, a high concentration of
unlabeled TEA or 1-methyl-4-phenylpyridinium inside the cells
stimulated the uptake of [14C]TEA (Zhang et
al., 1998b
). These data suggest that trans-stimulation studies may be useful in identifying substrates of hOCT1 in the HeLa
cell expression system.
Although our previous study demonstrated that structurally diverse organic cations interact with hOCT1, systematic studies ascertaining structure activity relationships were not performed. To obtain insight into the relationship between physicochemical properties, particularly hydrophobicity, and transport by hOCT1, we studied a series of n-tetraalkylammonium (n-TAA) compounds in hOCT1 transfected HeLa cells. By performing both trans-stimulation and cis-inhibition studies, we determined the effect of hydrophobicity on inhibition potency and translocation by hOCT1. For n-TAA compounds with molecular weights greater than or equal to 130, we observed a reverse correlation between IC50 and partition coefficient (octanol per water). A reverse correlation was also observed between rate of influx and partition coefficient, indicating that factors other than binding affinity contribute to the overall transport rate of these compounds by hOCT1. These data indicate that a balance between hydrophobic and hydrophilic properties is required for interaction and subsequent translocation by hOCT1.
Experimental Procedures
DNA Isolation.
hOCT1 DNA was subcloned into the mammalian
expression vector pTargeT (Promega, Madison, WI) as described
previously (Zhang et al., 1998b
). DNA for transfection studies was
isolated with the Qiagen Endo-free DNA isolation kit (Qiagen, Inc.,
Valencia, CA). The DNA was resuspended in endotoxin-free TE buffer and
its concentration was determined by UV spectroscopy.
Reverse Transcription-Polymerase Chain Reaction
(RT-PCR).
The first-strand cDNA for PCR amplification was
synthesized from mRNA isolated from various tissues or Caco-2 cells
with oligo(dT) primers using the SuperScript preamplification system
(Gibco-BRL, Gaithersburg, MD) (Zhang et al., 1997a
). The primers used
in PCR were designed from the hOCT1 cDNA sequence (5' and 3' end
primers in Zhang et al., 1997b
). PCR was performed in a thermal cycler (Perkin-Elmer, Foster City, CA) using the cycle as described previously (Zhang et al., 1997b
). The PCR products were electrophoresed through 1% agarose gel, eluted, and then subcloned into the pGEM-T vector (Promega Biotech). The vector inserts were sequenced by the
Biomolecular Resource Center at University of California-San Francisco
(Zhang et al., 1997a
,b
).
Maintenance of Cell Culture and Transfection.
HeLa cells
were maintained in growth medium in 175-ml cell culture flasks (Nalge
Nunc International, Napierville, IL) at 37°C in a humidified 5%
CO2/95% air atmosphere as described previously (Zhang et al., 1998b
). All studies were performed in cells of passages
3 to 19. Cells were seeded at a density of 1.6 × 105 cells/well in 12-well tissue culture plates
(Corning Costar Corp., Cambridge, MA) 24 h before transfection.
Lipofectamine reagent (Gibco-BRL) was used to deliver DNA to the
cells after a modified protocol from Gibco-BRL (Zhang et al., 1998b
).
Briefly, for each well, 1 µg of the purified plasmid DNA was added to
100 µl of Opti-MEM (Gibco-BRL) and 3.25 µl of lipid (2 mg/ml) was
added to another 100 µl of media. The two solutions were then mixed and incubated for 30 min at room temperature. After incubation, 800 µl of Opti-MEM was added to the 200-µl mixture. The final volume of
1-ml mixture was applied to each well after rinsing the cells with 1 ml
of the Opti-MEM. The cells were incubated for 18 h before the
transfection mixture was removed by aspiration and replaced with
standard complete growth medium.
Uptake Measurements.
In general, uptake studies were carried
out 24 to 44 h post-transfection as described previously (Zhang et
al., 1998b
). Briefly, the growth medium was gently aspirated and each
well was rinsed with 1 ml of PBS. To initiate uptake, 0.5 ml of PBS
containing 10 µM [14C]TEA was added to each
well. Inhibition and IC50 studies were carried
out by adding various concentrations of unlabeled compounds to the
reaction mixture. The uptake was carried out at room temperature for 20 min and stopped by aspiration of the uptake medium. The cell monolayers
of each well were immediately washed with 2 ml of ice-cold PBS buffer
once and 1 ml of the buffer twice. The cells were then solubilized with
1 ml 0.5% Triton X-100 and 0.5 ml of sample was assayed using liquid
scintillation counting (Beckman Instruments, Palo Alto, CA).
Efflux Studies. Efflux studies were carried out 24 to 44 h post-transfection. The cells were washed with 1 ml of PBS before preincubation with 10 µM [14C]TEA for 1 h at 37°C. The cells were then washed twice with 1 ml of ice-cold PBS. For the time course we added only PBS to the wells, and determined the concentration of [14C]TEA in 0.5-ml samples of the media at various times. In the trans-efflux studies, either 1 ml of PBS (control) or 1 ml of PBS with the indicated amount of unlabeled compound was added to each well of cells. After 10 min at room temperature, a 0.5-ml aliquot of incubation media was sampled and the concentration of [14C]TEA determined in the aliquot.
Partition Coefficient Determinations.
Octanol-water
partition coefficients were determined from an n-octanol and
water system at pH 7.4 (Neef and Meijer, 1984
). Briefly, 5 ml of 4 mM
procainamide, quinine, and quinidine water solutions were prepared.
Then each water solution was mixed with 5 ml of n-octanol by
vortexing. The mixture was rotated for 2 h at room temperature.
The layers were separated by centrifugation at 2500 rpm for 15 min.
Aliquots (100 µl) from each layer were diluted to 5 ml of water or
octanol. The concentration ratio of octanol to water was determined as
the ratio of UV absorbance from octanol to water solutions at
max. The
max value
for procainamide is 278 nm; for quinine and quinidine the value is 330 nm.
Data Analysis. In general, uptake values are expressed as mean ± S.E. or mean ± S.D. as indicated in the figurelegends. A minimum of two wells was used to generate a data point in each experiment. All experiments were repeated at least once on a different day using a different cell passage.
For IC50 studies, data were fit to the equation V = V0/[1+(I/IC50)n] where V is the uptake of [14C]TEA in the presence of inhibitor, V0 is the uptake of [14C]TEA in the absence of inhibitor, I is the inhibitor concentration, and n is the Hill coefficient. The KaleidaGraph fitting program (Abelbeck Software) was used to fit the data by nonlinear regression. Statistical analysis was carried out by comparing the tested compounds with the controls from the same experiments using the unpaired Student's t test (Primer of Biostatistics software, Version 3, written by Stanton A. Glantz, McGraw-Hill Companies, 1991). Results were considered statistically different with a probability of p <.05. Analysis using one-way ANOVA produced p values that were not different from those obtained using Student's t test.Materials. HeLa cells and all of the media and buffers used to maintain the cells were obtained from the University of California San Francisco Cell Culture Facility. Original stocks of HeLa cells were from American Type Culture Collection (Rockville, MD). Lipofectamine and Opti-MEM were purchased from Gibco-BRL (Gaithersburg, MD). All chemicals were obtained from Sigma (St. Louis, MO) and Fisher (Pittsburgh, PA) or as indicated. [14C]TEA (55 mCi/mmol) was purchased from American Radiolabeled Chemicals, Inc. (St. Louis, MO). The n-TAA compounds (i.e., M-methyl, E-ethyl, Pr-propyl, Bu-butyl, Pe-pentyl, and H-hexyl) and n-octanol were purchased from Aldrich Chemicals (Milwaukee, WI) and tributylmethylammonium (TBuMA) was purchased from Fluka Chemical Corp., (Ronkonkoma, NY).
| |
Results |
|---|
|
|
|---|
Tissue Distribution of hOCT1.
The tissue distribution of hOCT1
was determined by RT-PCR using primers derived from the hOCT1 cDNA
sequence (Zhang et al., 1997b
, Gorboulev et al., 1997
). Bands
corresponding to full-length hOCT1 were detected in human liver,
kidney, small intestine (data not shown), and Caco-2 cells (Fig.
1). The band from hOCT1 mRNA was
strongest in the liver (Fig. 1), indicating that hOCT1 mRNA transcripts
are expressed in abundance in human liver. Sequence analysis
demonstrated that the sequences of these PCR products were identical
with that of hOCT1.
|
Expression of hOCT1 in HeLa Cells.
Previous studies in this
laboratory demonstrated that hOCT1 can be transiently expressed in HeLa
cells (Zhang et al., 1998b
). In this study, we halved the amount of DNA
(i.e., 1 µg of DNA/well) used in transfection. With this
modification, we used less lipid while maintaining a lipid/DNA ratio of
6.5:1. Under these conditions, we observed an enhancement in TEA uptake
(data not shown) similar in magnitude to that observed in our previous
studies (Zhang et al., 1998b
).
Inhibition Studies. cis-Inhibition studies were carried out to determine whethern-TAA compounds inhibit the uptake of [14C]TEA in hOCT1 DNA-transfected HeLa cells. Tetramethylammonium (TMA) (50 µM or 10 mM) did not inhibit [14C]TEA uptake (data not shown), whereas (50 µM) unlabeled tetrapropylammonium (TPrA), TBA, tetrapentylammonium (TPeA), and tetrahexylammonium (THA) significantly inhibited [14C]TEA uptake with various degrees of inhibition (Fig. 2).
|
|
|
0.490 · N + 3.46, where
N = alkyl chain length, r2 = 0.990] (Fig. 4), suggesting that there
is a good correlation between IC50 values and
alkyl chain. Since alkyl chain length is related to the hydrophobicity
of these compounds, we further determined whether there was a
correlation between IC50 and partition coefficient (P) because hydrophobicity (or lipophilicity) can be
expressed as the partition coefficient between octanol and an aqueous
solution.
|
0.398 · log(P) + 1.44, r2 = 0.975 (Fig.
6).
|
|
0.393 · log(P) + 1.43, r2 = 0.974 (Fig. 6).
We also examined the relationship of IC50 values
and partition coefficients for nonaliphatic organic cations.
Octanol-water partition coefficient values of procainamide, quinine,
and quinidine were determined. As listed in Table
2, P for procainamide is .009, for
quinine is 2.32, and for quinidine is 2.45. When the nonaliphatic
compounds (procainamide, vecuronium, quinine, and quinidine) were
included, the relationship was log(IC50) =
0.383 · log(P) + 1.49, r2 = 0.859 (Fig. 6).
|
trans-Stimulation Studies.
trans-Stimulation studies have been used previously to
investigate whether an inhibitor might also be a substrate of hOCT1, i.e., translocated by hOCT1 (Zhang et al., 1998b
). Preincubated hOCT1
DNA-transfected HeLa cells with various concentrations of unlabeled TEA
exhibited trans-stimulation of
[14C]TEA influx. We observed that the magnitude
of the trans-stimulation effect increased with increasing
trans-TEA concentrations, and it was saturable at high
concentrations. When we incubated the cells with a concentration
representing 10 times the Km or
Ki value, i.e., 2 mM TEA, the
trans-stimulation effect was maximal (data not shown).
Therefore, we preincubated cells with concentrations approximately 10 times the Km or
Ki value of unlabeled test compounds under the assumption that this condition would produce a maximum trans-stimulation effect. As shown in Fig.
7, after preincubating hOCT1
cDNA-transfected HeLa cells with TEA (2 mM), TPrA (1 mM), TBuMA (1 mM),
or TBA (0.5 mM) for 1 h at 37°C,
[14C]TEA uptake was significantly enhanced
(p <.05) and the enhanced effect decreased with increasing
alkyl chain length. This trans-stimulation effect was not
observed in empty vector-transfected HeLa cells. Preincubating hOCT1
DNA-transfected cells with TMA (10 mM) or TPeA (0.2 mM) did not result
in a significant change in [14C]TEA uptake,
whereas preincubation of cells with 0.1 mM THA resulted in a
significant decrease (apparent trans-inhibition) of
[14C]TEA uptake (p <.05).
|
|
Efflux Studies. In further experiments we investigated the effect of the various n-TAA compounds on the efflux of [14C]TEA from cells preloaded with [14C]TEA. The efflux of [14C]TEA from HeLa cells transfected with hOCT1 plasmid DNA increased with time and was linear up to 40 min (data not shown). Therefore, further studies were carried out at 10 min. As shown in Fig. 9, after incubating the [14C]TEA preloaded cells with unlabeled TEA (2 mM), TPrA (1 mM), TBA (0.5 mM), and TBuMA (1 mM) for 10 min, efflux of [14C]TEA was significantly enhanced. Incubating with TMA (10 mM) and TPeA (0.2 mM) did not result in significant change in [14C]TEA efflux, whereas incubating the cells with THA (0.1 mM) resulted in a significant decrease of efflux (p <.05).
|
| |
Discussion |
|---|
|
|
|---|
Secretory transporters in the liver, kidney, and intestine play a
role in the elimination of organic cations from the body (Turnheim and
Lauterbach, 1977a
,b
; Miyamoto et al., 1988
; Pritchard and Miller, 1993
;
Oude Elferink et al., 1995
; Tomita et al., 1997
; Zhang et al., 1998a
).
hOCT1 appears to be predominantly involved in the uptake of organic
cations in the liver; however, data obtained in this study as well as
in our previous study (Zhang et al., 1997b
) demonstrate that hOCT1 mRNA
transcripts are present, although in much lower abundance, in kidney
and Caco-2 cells, a human colon carcinoma cell line (Fig. 1).
Functional studies of hOCT1 utilizing heterologous expression systems
(e.g., X. laevis oocytes and transfected HeLa cells) have
demonstrated that various organic cations as well as some neutral and
anionic compounds inhibit the transport of model organic cations by
hOCT1 (Zhang et al., 1997b
; 1998b
). The goal of the current study was
to use a series of n-TAA compounds to systematically determine the effect of hydrophobicity on inhibition potencies of
compounds in interacting with hOCT1. Furthermore, the effect of
hydrophobicity on the rate of transport (e.g., influx and efflux) by
hOCT1 was determined.
Initially, a good correlation between IC50 values
and alkyl chain length was found. Namely, we observed that
n-TAA compounds with the longer alkyl chain lengths were the
more potent inhibitors of hOCT1. This observation is consistent with
what is generally found for these compounds in inhibiting organic
cation transport (Dantzler et al., 1991
; Groves et al., 1994
; Ullrich
et al., 1991
; Wright et al., 1995
; Wright and Wunz, 1998
). In the
literature, a linear relationship between P values of the quaternary
ammonium cations (including n-TAAs) and MWs has been
reported (Neef and Meijer, 1984
). We used this relationship to estimate
the P values of several n-TAAs (Table 1). A good correlation
between IC50 and P in a double-logarithmic plot
was generated for homologous n-TAAs (i.e.,
log(IC50) =
0.398 · log(P) + 1.44, r2 = 0.975 (Fig. 6). The data indicate
that for inhibition, binding affinity is increased with increasing
hydrophobicity. This correlation also applies to TBuMA for which the
four alkyl chains are not of equal length (Fig. 6). Although
r2 was slightly reduced from 0.974 to
0.859 when data for nonaliphatic compounds were included in the same
plot (Fig. 6), a good relationship between IC50
and P value is still apparent; this suggests that a compound's
hydrophobicity is a major determinant of its potency of interaction
with hOCT1.
Inhibition does not necessarily imply that a compound is also
translocated by a transporter. Since radiolabeled n-TAA
compounds are not available except for TEA, we used
trans-stimulation studies to investigate whether the
n-TAA compounds might also be substrates of hOCT1.
trans-Stimulation is a frequently used method to test whether two molecules share a common transport pathway (Holohan and
Ross, 1980
; Miyamoto et al., 1988
; Dantzler et al., 1991
). If the
presence of the test compound on the opposite side (trans) of the membrane results in an enhanced flux of the radiolabeled probe,
the test compound is considered to be a substrate for the same
transporter as the probe, and vice versa. However if a compound does
not trans-stimulate or does trans-inhibit it may
or may not be a substrate (Busch et al., 1998
). Tracer flux experiments
are required to determine whether such compounds are in fact
substrates. trans-Stimulation has been used previously in
the hOCT1 DNA-transfected cell line to investigate whether an inhibitor
might also be a substrate (Zhang et al., 1998b
).
TMA did not trans-stimulate TEA influx or efflux; this is consistent with our inhibition study suggesting that TMA does not interact with hOCT1. For all other n-TAA compounds, we observed that compounds with shorter alkyl chain lengths (or smaller P, i.e., less lipophilic), TEA, TPrA, TBuMA, and TBA, produced trans-stimulation effects. However, the magnitude of the effect decreased with increasing alkyl chain length, in the [14C]TEA influx experiments, suggesting that the transport rate was decreased (Fig. 7). In contrast, compounds with a longer alkyl chain length (or larger P, i.e., more lipophilic), TPeA and THA, did not demonstrate a trans-stimulation effect. Moreover, THA demonstrated an apparent trans-inhibition effect, suggesting that the transporter loaded with THA has a slower turnover rate than that of the unloaded transporter. The compounds which trans-stimulated [14C]TEA influx (Fig. 7) were also shown to trans-stimulate [14C]TEA efflux from cells preloaded with [14C]TEA (Fig. 9). However, notable differences in the trans-stimulation effect of TBuMA on [14C]TEA influx versus efflux were observed, suggesting that hOCT1 may have asymmetrical binding sites.
An alternative explanation of the apparent trans-stimulation effect could be that n-TAA compounds might interact with a site not related directly to the transporter (e.g., an ion channel in the cells) and alter the membrane potential. Since hOCT1 is a potential-dependent transporter, an effect on membrane potential would alter [14C]TEA influx or efflux. Because of the low activity of the expressed transporter in the transfected cells, we were unable to perform studies under voltage-clamped conditions. Therefore, we cannot exclude indirect effects of the n-TAA compounds on membrane potential. However, unpublished data from this laboratory indicate that n-TAA compounds trans-stimulate [14C]TEA uptake by hOCT1 and by rOCT1 differently. If the trans-stimulation effects of the n-TAA compounds were solely due to indirect effects on membrane potential, the compounds should have produced similar trans-stimulation of [14C]TEA uptake in cells transfected with either hOCT1 or rOCT1.
Previously, it was shown that increasing lipophilicity is associated
with an increase in hepatic clearance of various compounds in the rat
(Neef and Meijer, 1984
; Proost et al., 1997
). These results are in
contrast to our data, which suggest that with increasing lipophilicity,
the efflux via hOCT1 decreases (Fig. 7). The discrepancies between our
data and the previous studies in the intact liver may be explained in
several ways. First, diffusional pathways as well as multiple
transporters on both the canalicular and sinusoidal membrane contribute
to hepatobiliary secretion in the intact organ or animal. Second, hOCT1
is a transporter cloned from human liver; species differences between
the structure activity relationships of the rat and human transporters
may be present. Previously, notable species differences in the effect
of hydrophobicity on transport of organic cations in rat and rabbit
kidney preparations were observed (Ullrich et al., 1991
; Groves et al.,
1994
).
In summary, our observations suggest that the longer the alkyl chain length (i.e., the more hydrophobic and bulkier), the higher the affinity of the tetraalkylammonium compounds for hOCT1, but the slower the rate of transport (i.e., poorer substrate) by hOCT1. hOCT1 may represent a human liver transporter which accepts smaller organic cations as its substrates. The correlation observed between IC50 and P values could be used to estimate the IC50 values of various n-alkylammonium compounds in interacting with hOCT1. A balance between hydrophobic and hydrophilic properties is required for efficient transport of an organic cation by hOCT1.
| |
Footnotes |
|---|
Accepted for publication October 19, 1998.
Received for publication June 24, 1998.
1 This study was supported by National Institutes of Health Grant GM-57656. L.Z. was supported in part by the University of California San Francisco Chancellor's Graduate Research Fellowship.
Send reprint requests to: Kathleen M. Giacomini, Ph.D., Department of Biopharmaceutical Sciences, University of California, San Francisco, 513 Parnassus, S-926, San Francisco, CA 94143-1936. E-mail: kmg{at}itsa.ucsf.edu
| |
Abbreviations |
|---|
hOCT1, human organic cation transporter; TEA, tetraethylammonium; TPrA, tetrapropylammonium; TBuMA, tributylmethylammonium; TPeA, tetrapentylammonium; THA, tetrahexylammonium; n-TAA, n-tetraalkylammonium; RT-PCR, reverse transcription-polymerase chain reaction; MW, molecular weight.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. V. S. Varma, A. H. Eriksson, G. Sawada, Y. A. Pak, E. J. Perkins, and C. L. Zimmerman Transepithelial Transport of the Group II Metabotropic Glutamate 2/3 Receptor Agonist (1S,2S,5R,6S)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY354740) and Its Prodrug (1S,2S,5R,6S)-2-[(2'S)-(2'-Amino)propionyl]aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY544344) Drug Metab. Dispos., January 1, 2009; 37(1): 211 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Proctor, D. L. Bourdet, and D. R. Thakker Mechanisms Underlying Saturable Intestinal Absorption of Metformin Drug Metab. Dispos., August 1, 2008; 36(8): 1650 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. White, V. A. Saunders, P. Dang, J. Engler, A. Venables, S. Zrim, A. Zannettino, K. Lynch, P. W. Manley, and T. Hughes Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity Blood, December 1, 2007; 110(12): 4064 - 4072. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kwok, A. Yamauchi, R. Rajesan, L. Chan, U. Dhillon, W. Gao, H. Xu, B. Wang, S. Takahashi, J. Semple, et al. Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Bourdet, J. B. Pritchard, and D. R. Thakker Differential Substrate and Inhibitory Activities of Ranitidine and Famotidine toward Human Organic Cation Transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3) J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1288 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sata, H. Ohtani, M. Tsujimoto, H. Murakami, N. Koyabu, T. Nakamura, T. Uchiumi, M. Kuwano, H. Nagata, K. Tsukimori, et al. Functional Analysis of Organic Cation Transporter 3 Expressed in Human Placenta J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 888 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Engel and J. Wang Interaction of Organic Cations with a Newly Identified Plasma Membrane Monoamine Transporter Mol. Pharmacol., November 1, 2005; 68(5): 1397 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Schmitt and H. Koepsell Alkali Cation Binding and Permeation in the Rat Organic Cation Transporter rOCT2 J. Biol. Chem., July 1, 2005; 280(26): 24481 - 24490. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Suhre, S. Ekins, C. Chang, P. W. Swaan, and S. H. Wright Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2 Mol. Pharmacol., April 1, 2005; 67(4): 1067 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lungkaphin, V. Chatsudthipong, K. K. Evans, C. E. Groves, S. H. Wright, and W. H. Dantzler Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules Am J Physiol Renal Physiol, January 1, 2004; 286(1): F68 - F76. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bednarczyk, S. Ekins, J. H. Wikel, and S. H. Wright Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1 Mol. Pharmacol., March 1, 2003; 63(3): 489 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lee, C. Ng, K. L. R. Brouwer, and D. R. Thakker Secretory Transport of Ranitidine and Famotidine across Caco-2 Cell Monolayers J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cova, U. Laforenza, G. Gastaldi, Y. Sambuy, S. Tritto, A. Faelli, and U. Ventura Guanidine Transport across the Apical and Basolateral Membranes of Human Intestinal Caco-2 Cells Is Mediated by Two Different Mechanisms J. Nutr., July 1, 2002; 132(7): 1995 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-S. Song, S.-J. Chung, and C.-K. Shim Contribution of ion pair complexation with bile salts to biliary excretion of organic cations in rats Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G515 - G525. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, W. Gorset, C. B. Washington, T. F. Blaschke, D. L. Kroetz, and K. M. Giacomini Interactions of HIV Protease Inhibitors with a Human Organic Cation Transporter in a Mammalian Expression System Drug Metab. Dispos., March 1, 2000; 28(3): 329 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Dresser, A. T. Gray, and K. M. Giacomini Kinetic and Selectivity Differences between Rodent, Rabbit, and Human Organic Cation Transporters (OCT1) J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1146 - 1152. [Abstract] [Full Text] |
||||
![]() |
J. E. van Montfoort, B. Hagenbuch, K. E. Fattinger, M. Müller, G. M. M. Groothuis, D. K. F. Meijer, and P. J. Meier Polyspecific Organic Anion Transporting Polypeptides Mediate Hepatic Uptake of Amphipathic Type II Organic Cations J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 147 - 152. [Abstract] [Full Text] |
||||
![]() |
G. Pietig, T. Mehrens, J. R. Hirsch, I. Cetinkaya, H. Piechota, and E. Schlatter Properties and Regulation of Organic Cation Transport in Freshly Isolated Human Proximal Tubules J. Biol. Chem., August 31, 2001; 276(36): 33741 - 33746. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||